Swiss Health Authorities Defend Covid Strategy

2026-04-19 11:05:34

(MENAFN- Swissinfo) Anne Lévy, the director of the Federal Office of Public Health (FOPH), has defended the order of 61 million doses of Covid-19 vaccine during the pandemic. Select your language

Generated with artificial intelligence. Listening: Swiss health authorities defend Covid strategy This content was published on April 19, 2026 - 11:21 2 minutes Keystone-SDA

Français fr L'OFSP défend la stratégie de la Suisse durant la pandémie de Covid Original Read more: L'OFSP défend la stratégie de la Suisse durant la pandémie de

+Get the most important news from Switzerland in your inbox

“At the start of the pandemic, competition for supplies was fierce,” Lévy said in an interview with the SonntagsBlick.“It wasn't clear which company had the best vaccines – imagine if we had bet on the wrong product or ordered too few doses,” she added.

Switzerland administered 17 million vaccine doses on its territory and sent eight million to other countries. The rest was partly either destroyed or not delivered, yet paid for.

SonntagsBlick pointed out that over 70% of the vaccine doses paid for by Switzerland were not used. Lévy responded that Switzerland followed a strategy“based on safety”. Parliamentary oversight also found the measures to be justified. In a pandemic, it is better to order too much than too little, she said.

Meanwhile by the start of 2026, Swiss authorities had logged 408 claims for compensation for vaccine-related damages. According to Lévy, 300 of these have been rejected after initial examination, two accepted and two refused, while others are still pending.
More More Swiss Politics Too many Covid doses: Switzerland's vaccine conundrum
This content was published on Jul 11, 2022 Switzerland is sitting on around 38 million excess Covid-19 vaccine doses to be used by the end of 2022. What will it do with them?
Read more: Too many Covid doses: Switzerland's vaccine conu

MENAFN19042026000210011054ID1111002779

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.